Images – pT3a clear-cell renal cell carcinoma in a renal allograft managed effectively with open partial nephrectomy

  • Jas Singh Section of Urology, Department of Surgery, University of Manitoba
  • Rachel Wong Max Rady College of Medicine, University of Manitoba
  • Rahul K. Bansal Section of Urology, Department of Surgery, University of Manitoba
Keywords: Renal cell carcinoma, Kidney transplant, Allograft, Partial nephrectomy

References

– Karczewski, M., Czapiewski, W., & Karczewski, J. Urologic de novo malignancies after kidney transplantation: A single center experience. Transplantation Proceedings, 2012. 44(5),1293-97.

– Elkentaoui, H., Robert, G., Pasticier, G., et al. Therapeutic management of de novo urological malignancy in renal transplant recipients: The experience of the French Department of Urology and Kidney Transplantation from Bordeaux. Urology, 2010, 75(1), 126-32.

– Melchior, S., Franzaring, L., Shardan, A., et al (2011). Urological de novo malignancy after kidney transplantation: A case for the urologist. The Journal of Urology. 2011, 185(2), 428-32.

– Penn, I., & Staezl, T. E. Malignant tumors arising de novo In immunosuppressed organ transplant recipients. Transplantation, 1972. 14(4), 407-17.

– Bieniasz, M., Chmura, A., Kwapisz, M.,et al. Renal tumor in allogeneic kidney transplant recipient. Transplantation Proceedings. 2016, 48(5), 1849-54.

– Faba, O. R., Breda, A., Gausa, L., et al. De novo urologic tumors in kidney transplant patients. Actas Urológicas Españolas (English Edition). 2015, 39(2), 122-27.

– Bustami, R. T., Ojo, A. O., Wolfe, R. et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. American Journal of Transplantation. 2004. 4(1), 87-93.

– Guba, M., Graeb, C., Jauch, K., et al. Pro- and anti-cancer effects of immunosuppressive agents used In organ transplantation. Transplantation. 2004.77(12), 1777-82.

– Euvrard, S., Morelon, E., Rostaing, L., et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. New England Journal of Medicine. 2012. 367(4), 329-39.

– Boissier, R., Hevia, V., Bruins, H. M., et al. The risk of tumour recurrence in patients undergoing renal transplantation for end-stage renal disease after previous treatment for a urological cancer: A Systematic review. European Urology, 2018. 73(1), 94-108.

– Ribal, M., Rodriguez, F., Musquera, M., et al. Nephron-sparing surgery for renal tumor: A choice of treatment in an allograft kidney. Transplantation Proceedings. 2006. 38(5), 1359-62.

- Barama, A., St-Louis, G., Nicolet, V., et al. Renal cell carcinoma in kidney allografts: A case series from a single center. American Journal of Transplantation. 2005. 5(12), 3015-18.

Published
2019-01-10
How to Cite
Singh, J., Wong, R., & Bansal, R. K. (2019). Images – pT3a clear-cell renal cell carcinoma in a renal allograft managed effectively with open partial nephrectomy. Canadian Urological Association Journal, 13(11). https://doi.org/10.5489/cuaj.5789
Section
Images in Urology